All Stories

  1. Addition of long-acting beta 2 -agonists to inhaled corticosteroids for chronic asthma in children
  2. Antileukotriene agents compared with placebo in children and adults with mild asthma
  3. Intermittent inhaled corticosteroid therapy versus placebo for persistent asthma in children and adults
  4. Inhaled corticosteroids' dose response impact on growth
  5. Cochrane in context: Inhaled corticosteroids in children with persistent asthma: effects on growth and dose-response effects on growth
  6. Effects of Inhaled corticosteroids on growth
  7. Inhaled anticholinergics and short-acting beta 2 -agonists for children with acute asthma
  8. Effect of Inhaled corticosteroids on growth
  9. Preschoolers with wheeze
  10. Addition to inhaled corticosteroids of long-acting beta2-agonists versus anti-leukotrienes for chronic asthma
  11. Addition of anti-leukotriene agents to inhaled corticosteroids in children with persistent asthma
  12. Intermittent versus daily inhaled corticosteroids for persistent asthma in children and adults
  13. Addition of anti-leukotriene agents to inhaled corticosteroids for adults and adolescents with persistent asthma
  14. Inhaled Corticosteroids for Patients with Asthma
  15. Intermittent versus daily inhaled corticosteroids for persistent asthma in children and adults
  16. Addition of inhaled anticholinergics to beta2-agonists for children with acute asthma in hospital
  17. Anti-leukotriene agents compared to inhaled corticosteroids in the management of recurrent and/or chronic asthma in adults and children
  18. Inhaled Corticosteroids for Children And Adults With Mild Persistent Asthma
  19. Intermittent versus daily inhaled corticosteroids for persistent asthma in children and adults
  20. Addition of anti-leukotriene agents to inhaled corticosteroids in children with persistent asthma
  21. Design, synthesis, and QSAR study of novel 2-(2,3-dioxo-2,3-dihydro-1H-indol-1-yl)-N-phenylacetamide derivatives as cytotoxic agents
  22. Design, synthesis and in vitro antibacterial and antifungal activities of some novel spiro[azetidine-2,3′-indole]-2,4(1′H)-dione
  23. Comparative Pharmacokinetics Profile of Vasa Swaras with Vasicine and Vasicinone
  24. Combination Therapeutic Approach for Asthma and Allergic Rhinitis
  25. Analytical method development and validation of mianserin hydrochloride and its metabolite in human plasma by LC–MS